Validation of Phase‐Resolved Functional Lung (PREFUL) Magnetic Resonance Imaging Pulse Wave Transit Time Compared to Echocardiography in Chronic Obstructive Pulmonary Disease
Open Access
- 6 December 2021
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 56 (2) , 605-615
Abstract
Background: Phase‐resolved functional lung (PREFUL) magnetic resonance imaging (MRI) pulmonary pulse wave transit time (pPTT) is a contrast agent free, vascular imaging biomarker, but has not been validated in chronic obstructive pulmonary disease (COPD).Purpose: To validate PREFUL with echocardiographic pPTT as a reference standard and to compare arterial/venous pPTT mapping with spirometry and clinical parameters.Study type: Prospective.Population: Twenty‐one patients (62% female) with COPD and 44 healthy participants (50% female).Field Strength/Sequence: 1.5 T; 2D‐spoiled gradient‐echo sequence.Assessment: Three coronal PREFUL MRI slices, echocardiography, and spirometry including forced expiratory volume in 1 second (FEV1, liter) and predicted defined as FEV1 in% divided by the population average FEV1%, were performed. Pulmonary pulse transit time from the main artery to the microvasculature (PREFUL pPTT), to the right upper lobe vein (PREFUL pPTTav, echo pPTTav), from microvasculature to right upper lobe vein (PREFULvein) and the ratio of PREFUL pPTT to PREFUL pPTTvein were calculated. Body mass index (BMI), Global Initiative for COPD (GOLD) stage 1–4, disease duration, and cigarette packs smoked per day multiplied by the smoked years (pack years) were computed.Statistical Tests: Shapiro–Wilk‐test, paired‐two‐sided‐t‐tests, Bland–Altman‐analysis, coefficient of variation, Pearson ρ were applied, pPTT data were compared between 21 subjects from the 44 healthy subjects who were age‐ and sex‐matched to the COPD cohort, P < 0.05 was considered statistically significant.Results: PREFUL pPTTav significantly correlated with echo pPTTav (ρ = 0.95) with 1.85 msec bias, 95% limits of agreement: 55.94 msec, −52.23 msec in all participants (P = 0.59). In the healthy participants, PREFUL and echo pPTTav significantly correlated with age (ρ = 0.81, ρ = 0.78), FEV1 (ρ = −0.47, ρ = −0.34) and BMI (ρ = 0.56, ρ = 0.51). In COPD patients, PREFUL pPTT significantly correlated with FEV1 predicted (ρ = −0.59), GOLD (ρ = 0.53), disease duration (ρ = 0.54), and pack years (ρ = 0.49).Data Conclusion: Arteriovenous PTT measured by PREFUL MRI corresponds precisely to echocardiography and appears to be feasible even in severe COPD.Evidence Level: 1Technical Efficacy: Stage 2Keywords
Funding Information
- Deutsche Zentrum für Lungenforschung
This publication has 32 references indexed in Scilit:
- Quantitative and Semiquantitative Measures of Regional Pulmonary Microvascular Perfusion by Magnetic Resonance Imaging and Their Relationships to Global Lung Perfusion and Lung Diffusing CapacityInvestigative Radiology, 2013
- Pulmonary Artery Distensibility in Chronic Obstructive Pulmonary DiseaseEchocardiography, 2013
- Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohortHeart, 2012
- COPD/Emphysema: The Vascular StoryPulmonary Circulation, 2011
- Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General PopulationCirculation, 2009
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Expert consensus document on arterial stiffness: methodological issues and clinical applicationsEuropean Heart Journal, 2006
- Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity MeasurementHypertension, 1995
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987
- Pulmonary Arterial Pulse Wave Velocity and Impedance in ManCirculation Research, 1969